About Alloy Therapeutics
Alloy Therapeutics is a company based in Lexington (United States) founded in 2017.. Alloy Therapeutics has raised $117 million across 2 funding rounds from investors including ARE, Mubadala and 8VC. Alloy Therapeutics has completed 1 acquisition, including deepCDR Biologics. Alloy Therapeutics offers products and services including Antibody Platforms, TCR Mimics, and Genetic Medicines. Alloy Therapeutics operates in a competitive market with competitors including Evotec, Crown Bioscience, Domainex, NIH and Viva Biotech, among others.
- Headquarter Lexington, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alloy Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$117 M (USD)
in 2 rounds
-
Latest Funding Round
$42 M (USD), Series D
Oct 03, 2022
-
Investors
ARE
& 8 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alloy Therapeutics
Alloy Therapeutics offers a comprehensive portfolio of products and services, including Antibody Platforms, TCR Mimics, and Genetic Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
End-to-end services for monoclonal and bispecific discovery
Platform for targeting intracellular peptides in oncology
Services for improving potency and delivery of ASO candidates
Unlock access to complete
Unlock access to complete
Funding Insights of Alloy Therapeutics
Alloy Therapeutics has successfully raised a total of $117M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $42 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $42.0M
-
First Round
First Round
(02 Apr 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series D - Alloy Therapeutics | Valuation | 8VC , Mubadala | |
| Apr, 2021 | Amount | Series C - Alloy Therapeutics | Valuation | 8VC , Presight Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alloy Therapeutics
Alloy Therapeutics has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include ARE, Mubadala and 8VC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in technology, life sciences, and related sectors.
|
Founded Year | Domain | Location | |
|
Thiel Capital is involved in investment and financial activities.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed by the Christian family office
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alloy Therapeutics
Alloy Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include deepCDR Biologics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostic and pharmaceutical products are manufactured by deepCDR Biologics.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Alloy Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alloy Therapeutics Comparisons
Competitors of Alloy Therapeutics
Alloy Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Domainex, NIH and Viva Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Cancer and CVMD drugs are developed using PDX models.
|
|
| domain | founded_year | HQ Location |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery and development research services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alloy Therapeutics
Frequently Asked Questions about Alloy Therapeutics
When was Alloy Therapeutics founded?
Alloy Therapeutics was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is Alloy Therapeutics located?
Alloy Therapeutics is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is Alloy Therapeutics a funded company?
Alloy Therapeutics is a funded company, having raised a total of $117M across 2 funding rounds to date. The company's 1st funding round was a Series C of $75M, raised on Apr 02, 2021.
What does Alloy Therapeutics do?
Alloy Therapeutics was founded in 2017 and is headquartered in Lexington, United States. Operations focus on the biotechnology sector, where drug discovery services are delivered to support pharmaceutical innovation. Expertise is applied in early-stage research and development processes, including target identification and validation. The companys platform facilitates collaborative efforts with partners across the industry, emphasizing efficient workflows in therapeutic advancement.
Who are the top competitors of Alloy Therapeutics?
Alloy Therapeutics's top competitors include Evotec, Crown Bioscience and NIH.
What products or services does Alloy Therapeutics offer?
Alloy Therapeutics offers Antibody Platforms, TCR Mimics, and Genetic Medicines.
How many acquisitions has Alloy Therapeutics made?
Alloy Therapeutics has made 1 acquisition, including deepCDR Biologics.
Who are Alloy Therapeutics's investors?
Alloy Therapeutics has 9 investors. Key investors include ARE, Mubadala, 8VC, Thiel Capital, and Presight Capital.